Eude F, Guisier F, Salaun M, Thiberville L, et al. Prognostic value of total tumour volume, adding necrosis to metabolic tumour volume, in advanced or metastatic non-small cell lung cancer treated with first-line pembrolizumab. Ann Nucl Med 2022;36:224-234.
PMID: 35060071